Vertaling van "related practices " (Nederlands → Frans) :

TERMINOLOGIE

ADTKD-UMOD - UMOD-related autosomal dominant tubulointerstitial kidney disease
néphropathie tubulo-interstitielle autosomique dominante associée à UMOD

acquired immunodeficiency syndrome [AIDS] NNO | AIDS-related complex [ARC] NNO
Complexe relatif au SIDA [ARC] SAI Syndrome d'immunodéficience acquise [SIDA] SAI

ADTKD-MUC1 - MUC1-related autosomal dominant tubulointerstitial kidney disease
néphropathie tubulo-intersitielle autosomique dominante associée à MUC1

IN-CONTEXT TRANSLATIONS

Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices. European Commission, Ispra, VA, Italy 21-37.
Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra, VA, Italy 21-37.

Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra,VA,Italy 2003; 89-92.
Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra, VA, Italy 2003; 89-92.

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

Ook in Europese context wordt de toestemming van de patiënt als “good medical practice” bestempeld, zoals blijkt: “Although consent can be presumed for the recording and sharing of information required for healthcare within the immediate healthcare team, it is good practice to obtain specific consent for this process, particularly in relation to sensitive information.
Le consentement du patient est également considéré dans le contexte européen comme une « good medical practice », ainsi : « Bien que le consentement soit présumé pour l’enregistrement et le partage d’informations requises pour la prestation des soins de santé au sein de l’équipe directe de soins, il est judicieux, dans la pratique, d’obtenir un accord spécifique pour ceci, particulièrement pour ce qui concerne des informations sensibles.

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

[http ...]
[http ...]

De prijswinnaars en de eervolle vermeldingen promoten veilige en gezonde werkmethoden bij de risicobeoordeling van de werkplek. Hun initiatieven vindt u in de brochure over goede praktijken (in het Engels): Prevention of risk in practice: Good practice related to risk assessment.
Les lauréats et candidats mis à l'honneur promeuvent les bonnes pratiques en matière de sécurité et de santé dans le contexte de l'évaluation des risques sur le lieu de travail, illustrées dans la brochure consacrée aux bonnes pratiques (en anglais): Prevention of risk in practice: Good practice related to risk assessment.

OESO, Measuring Expenditure on Health-related R&D, 2001 en OESO, Frascati Manual 2002, The Measurement of Scientifi c and Technological Activities, Proposed Standard Practice for Surveys on Research and Experimental Development, 2002.
OCDE, Measuring Expenditure on Health-related R&D, 2001, et Frascati Manual 2002, The Measurement of Scientifi c and Technological Activities, Proposed Standard Practice for Surveys on Research and Experimental Development.

Thus the sale of non-prescription drugs over the Internet is regulated in it, “Good dispensing pharmaceutical practices” are stipulated and rules relating to the organisation of the night-duty service are established.
Thus the sale of non-prescription drugs over the Internet is regulated in it, “Good dispensing pharmaceutical practices” are stipulated and rules relating to the organisation of the night-duty service are established.